CTI BioPharma
CTIC
#5720
Rank
C$1.63 B
Marketcap
C$12.43
Share price
0.00%
Change (1 day)
25.30%
Change (1 year)

CTI BioPharma (CTIC) - Total assets

Total assets on the balance sheet as of March 2023 : C$0.15 Billion

According to CTI BioPharma 's latest financial reports the company's total assets are C$0.15 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)

Total assets by year

Year Total assets Change
2022-12-31C$0.17 B85.1%
2021-12-31C$92.31 M24.31%
2020-12-31C$74.26 M22.86%
2019-12-31C$60.44 M-50.6%
2018-12-31C$0.12 B77.33%
2017-12-31C$69 M-19.57%
2016-12-31C$85.79 M-57.15%
2015-12-31C$0.20 B86.95%
2014-12-31C$0.10 B7.35%
2013-12-31C$99.76 M36.11%
2012-12-31C$73.3 M15.78%
2011-12-31C$63.3 M18.18%
2010-12-31C$53.57 M-26.84%
2009-12-31C$73.22 M-6.25%
2008-12-31C$78.11 M6.51%
2007-12-31C$73.33 M-38.14%
2006-12-31C$0.11 B-34.49%
2005-12-31C$0.18 B-18.55%
2004-12-31C$0.22 B17.25%
2003-12-31C$0.18 B-35.76%
2002-12-31C$0.29 B-39.04%
2001-12-31C$0.48 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
C$151.73 B 98,721.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$153.82 B 100,081.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$123.27 B 80,188.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
C$27.42 B 17,762.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$9.51 B 6,097.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$123.13 B 80,096.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$55.72 B 36,194.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel